Derangement of warfarin anti-coagulation by miconazole oral gel

British Dental Journal

Volumn 184, Issue 2, 1998, Pages 68-69

  Pemberton, M N ^a   Sloan, P ^a   Ariyaratnam, S ^a   Thakker, N S ^a   Thornhill, M H ^a  

^a UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; MICONAZOLE; WARFARIN;

AGED; ARTICLE; BLOOD CLOTTING; CASE REPORT; CHEMICALLY INDUCED DISORDER; CONTUSION; DRUG EFFECT; DRUG INTERACTION; FEMALE; GEL; HUMAN; MALE; MELENA; MICROBIOLOGY; MIDDLE AGED; MOUTH DISEASE; ORAL DRUG ADMINISTRATION; PURPURA; STOMATITIS; THRUSH;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ANTIFUNGAL AGENTS; BLOOD COAGULATION; CANDIDIASIS, ORAL; CONTUSIONS; DRUG INTERACTIONS; FEMALE; GELS; HUMANS; MALE; MELENA; MICONAZOLE; MIDDLE AGED; MOUTH DISEASES; PURPURA; STOMATITIS, DENTURE; WARFARIN;

EID: 0032561839     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4809547     Document Type: Article

References (18)

1. Wood G D, Dreeble T. Warfarin; danger with antibiotics. Dent Update 1993; 20: 350-353.
2. Baciewicz A M, Menke J J, Bokar J A, Baub E B. Fluconazole-warfarin interaction. Ann Pharmacother 1994; 28: 1111.
3. Ariyaratnam S, Thakker N S, Sloan P, Thornhill M H. Drug points: potentiation of warfarin anticoagulant activity by miconazole oral gel. Br MedJ 1997; 314: 349.
4. Dental Practitioners' Formulary. No. 32. p 20. London: BDA, BMA, RPS, 1996.
5. O'Reilly R A, Goulart D A, Kunze K L, et al. Mechanisms of stereoselective interaction between miconazole and racemic warfarin in human subjects. Clin Pharmacol Ther 1992; 51: 656-667.
6. Colquhoun M C, Daly M, Stewart P, Beeley L. Interaction between warfarin and miconazole oral gel (letter). Lancet 1987; 1: 695-696.
7. Shenfield G M, Page M. Potentiation of warfarin action by miconazole oral gel (letter). Aust NZ J Med 1991; 21: 928.
8. Evans I, Orme D S, Sedgewick M L, Youngs G R. Treating oral candidiasis: potentially fatal (letter). Br Dent J 1997; 182: 452.
9. Pemberton M, Sloan P, Ariyaratnam S, Thakker N S, Thornhill M II. Treating oral candidiasis: potentially fatal (letter). Br Dent J 1997; 183: 87.
10. Brugmans J, Van Custem J, Heykants J, Schuermans V, Theinnpoint D. Systemic antifungal potential, safety, biotransformation and transformation of miconazole nitrate. Eur J Clin Pharmacol 1972; 5: 93-99
11. Marotel C, Cerisay D, Vasseur P, Rouvier B, Chabanne JP. Potentialisation des effets de l'acenocoumarol par le gel buccal de miconazole. Paris Medicale 1986; 15: 1684-1685.
12. Ducroix J P, Small A, Sevenet F, Andrejak M, Baillet J. Hematome oesophagien secondaire a une potentialisation des effets de Pacenocoumarol par le gel buccal de miconazole. Rev Med Interne 1989; 10: 557-559.
13. Ponge T, Rapp M J, Fruneau P, et al. Interaction medicamenteuse impliquant le miconazole en gel et la fluindione. Therapie 1987; 42: 412-413.
14. Bradley C P, Bond C. Increasing the number of drugs available over the counter: arguments for and against. Br J Gen Pract 1995; 45: 553-556.
15. Paris D G, Parente T F, Bruschetta H R, Guzman E, Niarches A P. Torsades de pointes induced by erythromycin and terfenadine. Am J Emerg Med 1994; 12: 636-638.
16. Smith S J. Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg 1994; 111: 348-354.
17. Goss J E, Ramo B W, Blake K. Torsades de pointes associated with astemizole (Hismanal) therapy. Arch intern Med 1993; 153: 2705.
18. Committee on safety of Medicines, Medicines Control Agency. Current Problems in Pharmacovtgilance 1997; 23: 9.